AIM ImmunoTech Inc. (AIM): Capital Expenditures

Annual figures by period end, from SEC filings.

$18.0K
Year ended 2024-12-31
-24.0%
3-year compound annual growth
-23.3%
5-year compound annual growth
-28.3%
10-year compound annual growth
$5.75M2009-12-31: $332.0K2010-12-31: $729.0K2011-12-31: $1.80M2012-12-31: $5.75M2013-12-31: $898.0K2014-12-31: $504.0K2015-12-31: $240.0K2016-12-31: $160.0K2017-12-31: $20.0K2018-12-31: $51.0K2019-12-31: $68.0K2020-12-31: $22.0K2021-12-31: $41.0K2022-12-31: $86.0K2024-12-31: $18.0K$18.0K
2009-12-31 Capital Expenditures (USD) 2024-12-31
Period endedCapital ExpendituresChange YoYSource filing
2024-12-31$18.0Kn/a2026-03-27, From 2024-01-01
No annual figure between 2022-12-31 and 2024-12-31.
2022-12-31$86.0K+109.8%2024-04-01, From 2022-01-01
2021-12-31$41.0K+86.4%2023-03-31, From 2021-01-01
2020-12-31$22.0K-67.6%2022-03-31, From 2020-01-01
2019-12-31$68.0K+33.3%2021-03-31, From 2019-01-01
2018-12-31$51.0K+155.0%2020-03-30, From 2018-01-01
2017-12-31$20.0K-87.5%2019-04-01, From 2017-01-01
2016-12-31$160.0K-33.3%2018-03-30, From 2016-01-01
2015-12-31$240.0K-52.4%2018-03-30, From 2015-01-01
2014-12-31$504.0K-43.9%2017-03-31, From 2014-01-01
2013-12-31$898.0K-84.4%2016-03-29, From 2013-01-01
2012-12-31$5.75M+219.4%2015-03-19, From 2012-01-01
2011-12-31$1.80M+147.2%2014-03-14, From 2011-01-01
2010-12-31$729.0K+119.6%2013-03-18, From 2010-01-01
2009-12-31$332.0Kn/a2012-03-14, From 2009-01-01